Losing weight can be difficult, especially when appetite, cravings, metabolism, or other health factors make lifestyle changes harder to maintain. Tirzepatide weight loss may offer another option for adults who need medical support while working toward healthier, sustainable weight management. At Addis Health & Wellness Center in Alexandria, VA, treatment begins with understanding your health history, goals, current medications, and individual needs rather than treating every patient the same. Tirzepatide works on two hormone pathways involved in appetite and blood sugar regulation, and it is used alongside nutrition and physical activity as part of an overall weight-management plan. If you are considering tirzepatide, a personalized consultation can help you understand whether this approach is appropriate for you and what your treatment plan may involve.
Medically Supervised
Open 24 Hours
Alexandria, VA 22312
5-Star Rated
$100
OFF All Services
Free Consultation
Find Out What's
Really Happening
No obligation. Personalized answers.
Confidential · No cost · Same-day appointments available
The Addis Difference
Tirzepatide is a prescription medication that acts on two hormone receptors: glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). These pathways are involved in appetite, food intake, and blood sugar regulation.
For chronic weight management, the FDA-approved tirzepatide product Zepbound is indicated for adults with obesity, or adults who are overweight and have at least one weight-related health condition. It is used together with a reduced-calorie diet and increased physical activity.
The goal is not simply to take a medication and hope for a quick change. Effective medical weight management usually involves looking at the bigger picture, including eating habits, activity, health history, medications, treatment response, and long-term goals.
At Addis Health & Wellness Center, a consultation provides an opportunity to discuss whether tirzepatide fits into that broader approach for you.
Weight management is influenced by more than willpower. Appetite regulation, hormones, sleep, activity, medications, medical conditions, and eating patterns can all affect a person’s ability to lose and maintain weight.
Tirzepatide may help appropriate patients manage appetite and food intake while they work on the lifestyle habits that support long-term weight management. It is not intended to replace healthy eating, physical activity, or ongoing medical care.
The right approach also varies from person to person. Some patients may respond well to one medication, while others may need a different strategy.
Tirzepatide activates both GIP and GLP-1 receptors. These hormone pathways can influence appetite and food intake, which is one reason the medication may help people consume fewer calories.
Tirzepatide is administered as a subcutaneous injection, typically once each week when prescribed for weight management. The FDA-approved prescribing information uses a gradual dose-escalation approach rather than starting patients immediately at a higher dose. The current prescribing information lists 2.5 mg once weekly as the starting dosage for four weeks, followed by increases based on treatment response and tolerability. Recommended maintenance doses for weight reduction and long-term maintenance are 5 mg, 10 mg, or 15 mg once weekly, with 15 mg as the maximum recommended dose.
Your individual dose should be determined by your healthcare provider. Do not change the amount or frequency on your own.
Starting with a lower dose and increasing gradually can help your provider balance treatment response with tolerability. Gastrointestinal effects are among the most common side effects associated with tirzepatide, including nausea, diarrhea, vomiting, constipation, abdominal discomfort, and indigestion.
That means treatment is not simply about reaching a particular dose as quickly as possible. Your provider can consider how you are responding and whether side effects are affecting your daily life.
Tirzepatide may provide several potential benefits for appropriate patients when used as part of a comprehensive weight-management plan.
Because tirzepatide acts on hormone pathways involved in appetite and food intake, some patients may find it easier to manage hunger and portion sizes while using the medication.
Tirzepatide is FDA-approved for chronic weight management in adults who meet specific criteria. Clinical trials used in the FDA approval evaluated tirzepatide alongside a reduced-calorie diet and increased physical activity.
That does not mean every patient will experience the same result. Response varies, and your healthcare provider can help you set realistic expectations.
Weight loss is only part of the conversation. Maintaining progress is often an important part of medical weight management. The FDA-approved indication for Zepbound includes both reduction of excess body weight and long-term maintenance of weight reduction.
A treatment plan may therefore include ongoing follow-up, nutrition guidance, physical activity, and adjustments based on how your body responds.
For someone who has tried to lose weight without reaching or maintaining their desired progress, medically supervised treatment can provide additional structure. Instead of relying on a generic diet plan, your provider can review your individual situation and determine which options may make sense.
Tirzepatide is not appropriate for everyone.
For the FDA-approved chronic weight-management indication, Zepbound is intended for adults with obesity or adults with overweight who have at least one weight-related medical condition. It is prescribed alongside a reduced-calorie diet and increased physical activity.
A healthcare professional should determine whether tirzepatide is appropriate based on your medical history and individual circumstances.
During a consultation, your provider may consider factors such as:
Tirzepatide should not be viewed as a universal solution. The purpose of an evaluation is to determine whether the potential benefits make sense for your particular situation.
Zepbound is contraindicated in people with a personal or family history of medullary thyroid carcinoma (MTC), people with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), and people with a known serious hypersensitivity to tirzepatide or its ingredients.
Your provider should also know if you have a history of pancreatitis, severe gastrointestinal disease, gallbladder problems, kidney problems, diabetic retinopathy, or other relevant medical conditions.
Pregnancy is another important consideration. The prescribing information states that tirzepatide may cause fetal harm and should be discontinued when pregnancy is recognized.
This is why an appropriate medical evaluation should come before starting treatment.
Your visit begins with a conversation about what you want to accomplish.
You can discuss your weight-management history, appetite concerns, lifestyle, previous attempts at weight loss, medications, and any health issues that may affect treatment.
This is also the right time to ask questions about side effects, dosing, cost, follow-up, and what realistic progress may look like.
Your provider can review information needed to determine whether tirzepatide may be suitable for you.
This may include your medical history, medications, weight-related health factors, and other information relevant to safe treatment.
The goal is to make the treatment plan personal rather than automatically prescribing the same approach to every patient.
If tirzepatide is considered appropriate, your provider can explain how the medication should be administered and how dosing may progress.
For FDA-approved Zepbound, the medication is injected under the skin once weekly, with dose increases made gradually based on the prescribing schedule, response, and tolerability.
Your provider should give you clear instructions on administration and what to do if you experience side effects or have questions about your dose.
Weight management is an ongoing process.
Follow-up allows your provider to assess how you are responding, discuss side effects, review progress toward your goals, and determine whether adjustments are appropriate.
Your plan may also address nutrition, physical activity, and habits that can support weight management beyond medication.
The most common adverse reactions associated with Zepbound include nausea, diarrhea, vomiting, constipation, abdominal pain or discomfort, indigestion, injection-site reactions, fatigue, burping, hair loss, and gastroesophageal reflux disease.
Many gastrointestinal effects are especially relevant when treatment is being started or doses are increased.
Tirzepatide also carries important warnings and precautions, including severe gastrointestinal reactions, acute kidney injury, gallbladder disease, pancreatitis, serious allergic reactions, and hypoglycemia in certain circumstances.
The medication also carries a boxed warning related to thyroid C-cell tumors based on findings in rats. It is not known whether this risk applies to humans, but people with a personal or family history of MTC or MEN 2 should not use Zepbound.
If you develop concerning or severe symptoms while taking tirzepatide, contact your healthcare provider promptly. Severe symptoms may require urgent medical attention.
Tirzepatide is one option within the broader medical weight-loss field.
Another commonly discussed option is semaglutide, which works through the GLP-1 pathway. The two medications are not identical, and neither is automatically the best choice for every person.
If you are comparing options, your provider can review your health history, goals, current medications, potential risks, and treatment preferences.
For patients considering different medication approaches, our medical weight loss services can provide a broader starting point for understanding available options.
Likewise, patients who are specifically considering semaglutide injections in Alexandria, VA may benefit from discussing how that option compares with tirzepatide during a consultation.
Tirzepatide should not be combined with another tirzepatide-containing product or a GLP-1 receptor agonist unless specifically directed within appropriate medical care; the FDA-approved labeling does not recommend such coadministration.
Patients sometimes encounter compounded versions of GLP-1 medications when researching weight loss online.
This is an area where careful medical guidance matters. The FDA has reported adverse events associated with compounded semaglutide and tirzepatide, including problems related to dosing errors. The agency has specifically encouraged healthcare professionals and patients to pay close attention to dosing and administration of compounded products.
If a compounded medication is being discussed as part of your care, ask your provider exactly what medication is being prescribed, how it should be measured, how it should be administered, and why that particular product is being considered.
For people in Alexandria, weight management has to fit into real life.
Someone living near Old Town may have a different daily routine from someone commuting through Eisenhower East or balancing work and family responsibilities around Del Ray and nearby Northern Virginia communities. A practical treatment plan should account for those realities rather than treating weight management as a short-term project.
Having a healthcare provider in Alexandria can also make follow-up more practical. Regular check-ins can be useful when you are starting treatment, adjusting to a medication, or working on long-term habits.
At Addis Health & Wellness Center, the focus should be on understanding your goals and health needs before deciding whether tirzepatide is appropriate. If you are searching for tirzepatide weight loss in Alexandria, VA, a consultation is a useful first step because it gives you a chance to ask questions and understand your options before committing to treatment.
There is no single weight-loss plan that works exactly the same way for everyone.
Your medical history, current medications, eating patterns, activity level, treatment response, and health goals can all affect the right approach. A medication that is appropriate for one person may not be appropriate for another.
Personalized care also helps address what happens beyond the initial prescription.
Weight management may involve nutrition, physical activity, sleep, behavioral habits, medication management, and follow-up. Looking at those pieces together can create a more complete plan than focusing only on the number on the scale.
If your goal is to lose weight and support long-term weight management, the first step is understanding which options fit your individual situation
Tirzepatide is used as part of a comprehensive weight-management approach for appropriate adults with obesity, or adults with overweight and at least one weight-related health condition. The FDA-approved Zepbound indication includes use alongside a reduced-calorie diet and increased physical activity.
For FDA-approved Zepbound, tirzepatide is administered as a subcutaneous injection once weekly. Dosing begins at a lower level and is increased gradually based on the prescribing information, treatment response, and tolerability.
Response varies from person to person. Some people notice changes in appetite before seeing substantial changes in weight, while others may progress differently. Your provider can help you establish realistic expectations and monitor your response over time.
There is no appropriate single number to promise an individual patient. Results vary based on factors such as treatment response, dose, health history, nutrition, activity, and how consistently the overall plan is followed. Clinical trial results should not be treated as a guarantee of what one patient will experience.
Common side effects include nausea, diarrhea, vomiting, constipation, abdominal discomfort, indigestion, fatigue, injection-site reactions, burping, hair loss, and reflux.
No medication is appropriate for everyone. Tirzepatide has specific contraindications and warnings, including a contraindication for people with a personal or family history of medullary thyroid carcinoma or MEN 2. Your healthcare provider should review your medical history before treatment.
The FDA-approved Zepbound labeling does not recommend combining it with another tirzepatide-containing product or a GLP-1 receptor agonist. Discuss all prescription medications, over-the-counter products, and supplements with your healthcare provider before starting treatment.
Yes. FDA-approved Zepbound is indicated for use alongside a reduced-calorie diet and increased physical activity. Medication can be one part of a broader weight-management plan rather than a replacement for healthy lifestyle habits.
The appropriate length of treatment depends on your individual response, health goals, and medical situation. Because chronic weight management includes maintaining weight reduction, your provider may discuss ongoing treatment and follow-up rather than treating weight loss as a short-term program.
The cost can depend on the medication, treatment plan, consultation, follow-up needs, and whether insurance or another payment arrangement applies. Ask Addis Health & Wellness Center about current pricing and what is included before beginning treatment.
If you are considering tirzepatide weight loss in Alexandria, VA, start with a personalized conversation about your goals, health history, and treatment options. Addis Health & Wellness Center can help you understand whether this approach may be appropriate for you and what a medically supervised weight-management plan could look like.
Schedule a consultation to discuss tirzepatide and take the next step toward healthier, long-term weight management.
$100 Off All Services
Stop guessing. Start with a free consultation at our Alexandria clinic — and let lab results and medical evaluation guide your program for once.
Medically supervised · Personalized plans · Alexandria, Arlington, Fairfax, Springfield
get in touch
Book Your Free
Consultation Today
Fill out the form and our team will reach out to schedule your free consultation. In-person or by phone — whichever works for you.
Fax: 703 520 5373
info@addishealthva.com
Address
6601 Little River Tnpk, Suite 420
Alexandria, VA 22312
Hours
Open 24 Hours (Monday - Sunday)
✦ $100 Off All Services
Mention this offer when you book your free consultation. Valid for all services at our Alexandria clinic. New patients welcome.
Confidential · No cost · Same-day appointments available
